IRB Committee 2 is responsible for the full review of human subjects research protocols for the C.T. Bauer School of Business, the College of the Arts, and the College of Liberal Arts and Social Sciences (CLASS), with the exception of the Department of Health and Human Performance. IRB 2 does not review FDA-regulated research.
|Submission Deadlines||Meeting Dates*|
|Friday, September 9, 2016||Friday, September 23, 2016|
|Friday, October 14, 2016||Friday, October 28, 2016|
|Friday, November 4, 2016||Friday, November 18, 2016|
|Friday, November 23, 2016||Friday, December 9, 2016|
|Friday, January 13, 2017||Friday, January 27, 2017|
|Friday, February 10, 2017||Friday, February 24, 2017|
|Friday, March 10, 2017||Friday, March 24, 2017|
|Friday, April 14, 2017||Friday, April 28, 2017|
|Friday, May 12, 2017||Friday, May 26, 2017|
|Friday, June 9, 2017||Friday, June 23, 2017|
|Friday, July 14, 2017||Friday, July 28, 2017|
|Friday, August 11, 2017||Friday, August 25, 2017|
*Dates are subject to change without notice if circumstances require rescheduling.
Protocols falling under an expedited category and involving no more than minimal risk, as well as minor changes in approved full board protocols, may be reviewed under an expedited process. The Chair of IRB 2 either reviews or delegates the review to one or more experienced IRB members, who review the protocol under applicable regulations and either approves or requires modifications to the protocol prior to approval. An expedited reviewer may not disapprove a protocol, but may forward to the fully convened committee for further determination if warranted. Expedited submissions are considered on a rolling basis, thus turnaround time for these submissions is expected to be quicker than for protocols undergoing full board review.
Protocols falling under an exempt category defined under the federal regulations require administrative review by the IRB office to ensure that basic ethical principles, such as confidentiality of data and obtaining informed consent where applicable, are addressed. Applications for exempt protocols are reviewed by IRB staff on a rolling basis, thus turnaround time for these submissions is expected to be quicker than for protocols undergoing full board review.